Basic Information
Kaleido Biosciences Focuses on the Development of Microbiome-Related Drugs. Kaleido Biosciences has a broad product pipeline, with a few products already in early clinical development for rare genetic disorders, metabolic diseases, oncology, and opportunistic multidrug-resistant pathogens.
Kaleido Biosciences, Inc.
Bedford,Massachusetts,United States of America
51~100 people
January 01, 2015
--
info@kaleido.com
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios